The Physiological Role of Adenosine In The Central Nervous System

International Review of Neurobiology

Volumn 27, Issue C, 1985, Pages 63-139

  Dunwiddie, Thomas V ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENYLATE CYCLASE; ALCOHOL; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CELL SURFACE RECEPTOR; NARCOTIC AGENT; NEUROTRANSMITTER; PURINE RECEPTOR;

ANALGESIA; ANIMAL; ANIMAL BEHAVIOR; BRAIN CIRCULATION; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG INTERACTION; ELECTROPHYSIOLOGY; HUMAN; LOCOMOTION; METABOLISM; NERVE CELL INHIBITION; NERVE CONDUCTION; PHYSIOLOGY; REVIEW; SLEEP; SYNAPSE; TIME; VASODILATATION;

ADENOSINE; ADENYLATE CYCLASE; ANALGESIA; ANIMAL; BEHAVIOR, ANIMAL; BENZODIAZEPINES; BRAIN CHEMISTRY; CAFFEINE; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR CIRCULATION; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; ETHANOL; HUMAN; LOCOMOTION; NARCOTICS; NEURAL CONDUCTION; NEURAL INHIBITION; NEUROTRANSMITTERS; RECEPTORS, CELL SURFACE; RECEPTORS, PURINERGIC; SLEEP; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPSES; TIME FACTORS; VASODILATION;

EID: 0022332956     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(08)60556-5     Document Type: Article

References (274)

1. Aghajanian, G.K., Nature (London) 276 (1978), 186–188.
2. Barberis, C., Daudet, F., Charriere, B., Guibert, B., Leviel, V., Neuroci. Lett. 41 (1983), 179–182.
3. Barr, E., Daniell, L.C., Leslie, S.W., Biochem. Pharmacol. 34 (1985), 713–715.
4. Barraco, R.A., Coffin, V.L., Altman, H.J., Phillis, J.W., Brain Res. 272 (1983), 392–395.
5. Barraco, R.A., Aggarwal, A.K., Phillis, J.W., Moron, M.A., Wu, P.H., Neurosci. Lett. 48 (1984), 139–144.
6. Barraco, R.A., Swanson, T.H., Phillis, J.W., Berman, R.F., Neurosci. Lett. 46 (1984), 317–322.
7. Beck, D.W., Vinters, H.V., Moore, S.A., Hart, M.N., Cancilla, P.A., J. Neurochem. 41 (1983), 939–941.
8. Bender, A.S., Wu, P.H., Phillis, J.W., J. Neurochem. 36 (1981), 651–660.
9. Bender, A.S., Wu, P.H., Phillis, J.W., J. Neurochem. 37 (1981), 1282–1290.
10. Berkowitz, B.A., Tarver, J.H., Spector, S., Eur. J. Pharmacol. 10 (1970), 64–71.
11. Berne, R.M., Rubio, R., Curnish, R.R., Circ. Res. 35 (1974), 262–271.
12. Berne, R.M., Winn, H.R., Park, T.S., Welsh, J.E., Curnish, R.R., Rubio, R., Cervos-Navarro, J., Fritschka, E., (eds.) Cerebral Microcirculation and Metabolism, 1981, Raven, New York, 227–232.
13. Berne, R.M., Winn, H.R., Knabb, R.M., Ely, S.W., Rubio, R., Berne, R.M., Rall, T.W., Rubio, R., (eds.) Regulatory Function of Adenosine, 1983, Nijhoff, The Hague, 293–317.
14. Boulenger, J.-P., Patel, J., Marangos, P.J., Neurosci. Lett. 30 (1982), 161–166.
15. Boulenger, J.-P., Patel, J., Post, R.M., Parma, A.M., Marangos, P.J., Life Sci. 32 (1983), 1135–1142.
16. Bourke, R.S., Kimelberg, H.K., Daze, M.A., Brain Res. 154 (1978), 196–202.
17. Bourke, R.S., Waldman, J.B., Kimelberg, H.K., Barron, K.D., San Fillipo, B.D., Popp, J., Nelson, L.R., J. Neurosurg. 55 (1981), 364–370.
18. Bourke, R.S., Kimelberg, H.K., Daze, M.A., Church, G., Neurochem. Res. 8 (1983), 5–24.
19. Bruns, R.F., N. S. Arch. Pharmacol. 315 (1980), 5–13.
20. Bruns, R.F., Daly, J.W., Snyder, S.H., Proc. Natl. Acad. Sci. U.S.A. 77 (1980), 6892–6896.
21. Bruns, R.F., Katims, J.J., Annau, Z., Snyder, S.H., Daly, J.W., Neuropharmacology 22 (1983), 1523–1529.
22. Buckle, P.J., Haas, H.L., J. Physiol. (London) 326 (1981), 109–122.
23. Burnstock, G., Handb. Psychopharmacol. 5 (1975), 131–194.
24. Butt, N.M., Collier, H.O.J., Cuthbert, N.J., Francis, D.L., Saeed, S.A., Eur. J. Pharmacol. 53 (1979), 375–378.
25. Buyniski, J.P., Rapela, C.E., Am. J. Physiol. 217 (1969), 1660–1664.
26. Carney, J.M., Br. J. Pharmacol. 75 (1982), 451–454.
27. Chapman, A.G., Westerberg, E., Siesjo, B.K., J. Neurochem. 36 (1981), 179–189.
28. Clanachan, A.S., Johns, A., Paton, D.M., Neuroscience 2 (1977), 597–602.
29. Clark, R.B., Gross, R., Su, Y.F., Perkins, J.P., J. Biol. Chem. 249 (1974), 5296–5303.
30. Coffin, V.L., Carney, J.M., Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M., (eds.) Physiology and Pharmacology of Adenosine Derivatives, 1983, Raven, New York, 267–274.
31. Collier, H.O.J., Cuthbert, N.J., Francis, D.L., Fed. Proc., Fed. Am. Soc. Exp. Biol. 40 (1981), 1513–1518.
32. Cook, M.A., Hamilton, J.T., Okwuasuba, F.K., Nature (London) 271 (1978), 768–771.
33. Crawley, J.N., Patel, J., Marangos, P.J., Life Sci. 29 (1981), 2623–2630.
34. Crawley, J.N., Patel, J., Marangos, P.J., Neurosci. Lett. 36 (1983), 169–174.
35. Creager, R., Dunwiddie, T., Lynch, G., J. Physiol. (London) 299 (1980), 409–424.
36. Dacey, R.G., Duling, B.R., Am. J. Physiol. 243 (1982), H598–H606.
37. Daly, J.W., Cyclic Nucleotides in the Nervous System, 1977, Plenum, New York.
38. Daly, J.W., J. Med. Chem. 25 (1982), 197–207.
39. Daly, J.W., Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M., (eds.) Physiology and Pharmacology of Adenosine Derivatives, 1983, Raven, New York, 275–290.
40. Daly, J.W., Bruns, R.F., Snyder, S.H., Life Sci. 28 (1981), 2083–2097.
41. Damm, H.W., Müller, W.E., Wollert, U., Eur. J. Pharmacol. 55 (1979), 331–333.
42. Dar, M.S., Mustafa, S.J., Wooles, W.R., Life Sci. 33 (1983), 1363–1374.
43. Daval, J.L., Barberis, C., Biochem. Pharmacol. 30 (1981), 2559–2567.
44. Daval, J.L., Barberis, C., Gayet, J., Brain Res. 181 (1980), 161–174.
45. Davies, L.P., Baird-Lambert, J., Jamieson, D.D., Gen. Pharmacol. 13 (1982), 27–33.
46. Davies, L.P., Brown, D.J., Chen Chow, S., Johnston, G.A.R., Neurosci. Lett. 41 (1983), 189–193.
47. Dolphin, A.C., Archer, E.R., Neurosci. Lett. 43 (1983), 49–54.
48. Drury, A.N., Szent-Györgyi, A., J. Physiol. (London) 68 (1929), 213–237.
49. Dunwiddie, T.V., Epilepsia 21 (1980), 541–548.
50. Dunwiddie, T.V., J. Physiol. (London) 326 (1984), 294–301.
51. Dunwiddie, T.V., Fredholm, B.B., Br. J. Pharmacol., 77, 1982, 347P.
52. Dunwiddie, T.V., Fredholm, B.B., Naunyn-Schmiedeberg's Arch. Pharmacol. 326 (1984), 294–301.
53. Dunwiddie, T.V., Fredholm, B.B., Cooper, D.M.F., Seamon, K.B., (eds.) Advances in Cyclic Nucleotide and Protein Phosphorylation Research, 19, 1985, Raven, New York, 259–272.
54. Dunwiddie, T., Hoffer, B., Br. J. Pharmacol. 69 (1980), 59–68.
55. Dunwiddie, T.V., Worth, T., J. Pharmacol. Exp. Ther. 220 (1982), 70–76.
56. Dunwiddie, T., Hoffer, B., Fredholm, B.B., Naunyn-Schmiedeberg's Arch. Pharmacol. 316 (1981), 326–330.
57. Dunwiddie, T.V., Basile, A.S., Palmer, M.R., Life Sci. 34 (1984), 37–47.
58. Ebersolt, C., Perez, M., Bockaert, J., Brain Res. 213 (1981), 139–150.
59. Ebersolt, C., Premont, J., Prochiantz, A., Perez, M., Bockaert, J., Brain Res. 267 (1983), 123–129.
60. Ebstein, R.P., Daly, J.W., Cell. Mol. Neurobiol. 2 (1982), 193–204.
61. Edstrom, J.P., Phillis, J.W., Can. J. Physiol. Pharmacol. 54 (1976), 787–790.
62. Emerson, T.E., Raymond, R.M., Am. J. Physiol. 241 (1981), H134–H138.
63. Feldberg, W., Sherwood, S.L., J. Physiol. (London) 123 (1954), 148–167.
64. Forrester, T., Harper, A.M., MacKenzie, E.T., Thomson, E.M., J. Physiol. (London) 296 (1979), 343–355.
65. Fredholm, B.B., Acta Physiol. Scand. 96 (1976), 422–430.
66. Fredholm, B.B., Med. Biol. 60 (1982), 289–293.
67. Fredholm, B.B., Acta Physiol. Scand. 115 (1982), 283–286.
68. Fredholm, B.B., Hedqvist, P., Biochem. Pharmacol. 29 (1980), 1635–1643.
69. Fredholm, B.B., Persson, C.G.A., Eur. J. Pharmacol. 81 (1982), 673–676.
70. Fredholm, B.B., Vernet, L., Acta Physiol. Scand. 104 (1978), 502–504.
71. Fredholm, B.B., Vernet, L., Acta Physiol. Scand. 106 (1979), 97–107.
72. Fredholm, B.B., Jonzon, B., Lindgren, E., Lindstrom, K., J. Neurochem. 39 (1982), 165–175.
73. Fredholm, B.B., Gustafsson, L.E., Hedqvist, P., Sollevi, A., Berne, R.M., Rall, T.W., Rubio, R., (eds.) Regulatory Function of Adenosine, 1983, Nijhoff, The Hague, 479–495.
74. Fredholm, B.B., Herrera-Marschitz, M., Jonzon, B., Lindstrom, K., Ungerstedt, U., Pharmacol. Biochem. Behav. 19 (1983), 535–541.
75. Fredholm, B.B., Jonzon, B., Lindgren, E., Acta Physiol. Scand. 515 (1983), 7–10.
76. Fredholm, B.B., Lindgren, E., Lindstrom, K., Vernet, L., Acta Pharmacol. Toxicol. 53 (1983), 236–244.
77. Fredholm, B.B., Dunwiddie, T.V., Bergman, B., Lindstrom, K., Brain Res. 295 (1984), 127–136.
78. Fuxe, K., Ungerstedt, U., Med. Biol. 52 (1974), 48–54.
79. Galindo, A., Krnjević, K., Schwartz, S., J. Physiol. (London) 192 (1967), 359–377.
80. Gallant, C.A., Clement, J.G., Can. J. Physiol. Pharmacol. 59 (1981), 886–889.
81. Galloway, M.P., Roth, R.H., J. Pharmacol. Exp. Ther. 227 (1983), 1–8.
82. Geiger, J.D., Nagy, J.I., Brain Res. Bull. 13 (1984), 657–666.
83. Gilbert, R.M., Gibbins, R.J., Israel, Y., Kalant, H., Popham, R.E., Schmidt, W., Smart, R.G., (eds.) Research Advances in Alcohol and Drug Problems, 1976, Wiley, New York, 49–176.
84. Gilman, A.G., Schrier, B.K., Mol. Pharmacol. 8 (1972), 410–416.
85. Ginsborg, B.L., Hirst, G.D.S., J. Physiol. (London) 224 (1972), 629–645.
86. Ginzler, A.R., Musacchio, J.M., J. Pharmacol. Exp. Ther. 194 (1975), 757–782.
87. Goodman, R.R., Kuhar, M.J., Hester, L., Snyder, S.H., Science 220 (1983), 967–969.
88. Grant, S.J., Redmond, D.E., Eur. J. Pharmacol. 85 (1982), 105–109.
89. Green, R.D., Proudfit, H.K., Yeung, S.-M.H., Science 218 (1982), 58–61.
90. Gurll, N.J., Reynolds, D.G., Vargish, T., Lechner, R., J. Pharmacol. Exp. Ther. 220 (1982), 625–628.
91. Haas, H.L., Pflügers Arch., 400, 1984, R39.
92. Haas, H.L., Jefferys, J.G., Slater, N.T., Carpenter, D.O., Pflügers Arch. 400 (1984), 28–33.
93. Harms, H.H., Wardeh, G., Mulder, A.H., Eur. J. Pharmacol. 49 (1978), 305–308.
94. Harms, H.H., Wardeh, G., Mulder, A.H., Neuropharmacology 18 (1979), 577–580.
95. Harris, E.W., Cotman, C.W., Soc. Neurosci. Abstr., 9, 1983, 1141.
96. Haulica, I., Ababei, L., Brainsteanu, D., Topoliceanu, F., J. Neurochem. 21 (1973), 1019–1020.
97. Hayashi, E., Mori, M., Yamada, S., Kunimoto, M., Eur. J. Pharmacol. 48 (1978), 297–307.
98. Hazeki, O., Ui, M., J. Biol. Chem. 256 (1981), 2856–2862.
99. Hedner, T., Hedner, J., Wessberg, P., Jonason, J., Neurosci. Lett. 33 (1982), 147–151.
100. Helland, S., Broch, O.J., Ueland, P.M., Neuropharmacology 22 (1983), 915–917.
101. Henon, B.K., McAfee, D.A., J. Physiol. (London) 336 (1983), 607–620.
102. Henon, B.K., McAfee, D.A., Berne, R.M., Rall, T.W., Rubio, R., (eds.) Regulatory Function of Adenosine, 1983, Nijhoff, The Hague, 455–466.
103. Ho, I.K., Loh, H.H., Way, E.L., J. Pharmacol. Exp. Ther. 185 (1973), 336–340.
104. Hoffer, B.J., Siggins, G.R., Oliver, A.P., Bloom, F.E., Ann. N. Y. Acad. Sci. 185 (1971), 531–549.
105. Hoffman, W.E., Albrecht, R.F., Miletich, D.J., Stroke 15 (1984), 124–129.
106. Holaday, J.W., Faden, A.I., Martin, J.B., Reichlin, S., Blick, K.L., (eds.) Neurosecretion and Brain Peptides, 1981, Raven, New York, 421–434.
107. Hollins, C., Stone, T.W., J. Physiol. (London) 303 (1980), 73–82.
108. Hollins, C., Stone, T.W., Br. J. Pharmacol. 69 (1980), 107–112.
109. Hollins, C., Stone, T.W., Lloyd, H., Neurosci. Lett. 20 (1980), 217–221.
110. Holtzman, S.G., Life Sci. 33 (1983), 779–787.
111. Huang, M., Drummond, G.I., Mol. Pharmacol. 16 (1979), 462–472.
112. Jhamandas, K., Dumbrille, A., Can. J. Physiol. Pharmacol. 58 (1980), 1262–1278.
113. Jhamandas, K., Sawynok, J., Kosterlitz, H.W., (eds.) Opiates and Endogenous Opioid Peptides, 1976, Elsevier, Amsterdam, 161–168.
114. Jiang, Z.G., Chelack, B.J., Phillis, J.W., Can. J. Physiol. Pharmacol. 58 (1980), 1513–1515.
115. Johnson, P.M., Inesi, G., J. Pharmacol. Exp. Ther. 169 (1969), 308–314.
116. Jonzon, B., Lindstrom, K., Fredholm, B.B., Acta Pharmacol. Toxicoil., 51(Suppl. 11), 1982, 24.
117. Kassel, N.F., Boarini, D.J., Olin, J.J., Sprowell, J.A., J. Neurosurg. 58 (1983), 69–76.
118. Katims, J.J., Annau, Z., Snyder, S.H., J. Pharmacol. Exp. Ther. 227 (1983), 167–173.
119. Kobayashi, K., Kuroda, Y., Yoshioka, M., J. Neurochem. 36 (1981), 86–91.
120. Kontos, H.A., Wei, E.P., Fed. Proc., Fed. Am. Soc. Exp. Biol., 40, 1981, 454.
121. Kostopoulos, G.K., Phillis, J.W., Exp. Neurol. 55 (1977), 719–724.
122. Kovach, A.G.B., Dora, E., Szedlacsek, S., Koller, A., J. Cereb. Blood Flow Metab. 3 (1983), 51–61.
123. Kreutzberg, G.W., Barron, K.D., Schubert, P., Brain Res. 158 (1978), 247–257.
124. Krnjević, K., Physiol. Rev. 54 (1974), 418–540.
125. Kuroda, Y., McIlwain, H., J. Neurochem. 21 (1973), 889–900.
126. Kuroda, Y., Saito, M., Kobayashi, K., Proc. Jpn. Acad. 52 (1976), 86–89.
127. Kuroda, Y., Saito, M., Kobayashi, K., Brain Res. 109 (1976), 196–201.
128. Lee, K.S., Schubert, P., Emmert, H., Kreutzberg, G.W., Neurosci. Lett. 23 (1981), 309–314.
129. Lee, K., Schubert, P., Gribkoff, V., Sherman, B., Lynch, G., J. Neurochem. 38 (1982), 80–83.
130. Lee, K.S., Reddington, M., Schubert, P., Kreutzberg, G., Brain Res. 260 (1983), 156–159.
131. Lekic, D., Can. J. Physiol. Pharmacol. 55 (1977), 1391–1393.
132. Levine, A.S., Morley, J.E., Pharmacol. Biochem. Behav. 19 (1983), 23–26.
133. Lewin, E., Bleck, V., J. Neurochem. 33 (1979), 365–367.
134. Lewis, M.E., Patel, J., Edley, S.M., Marangos, P.J., Eur. J. Pharmacol. 73 (1981), 109–110.
135. Livemore, P., Mitchell, G., J. Cereb. Blood Flow Metab. 3 (1983), 529–534.
136. Londos, C., Cooper, D.M.F., Wolff, J., Proc. Natl. Acad. Sci. U.S.A. 77 (1980), 2551–2554.
137. Lundberg, D.B., Breese, G.R., Mueller, R.A., J. Pharmacol. Exp. Ther. 217 (1981), 215–221.
138. McIlwain, H., Biochem. Soc. Symp. 36 (1974), 69–85.
139. Mah, H.D., Daly, J.W., Pharmacol. Res. Commun. 8 (1976), 65–79.
140. Maitre, M., Cielsielski, L., Lehmann, A., Kempf, E., Mandel, P., Biochem. Pharmacol. 23 (1974), 2807–2816.
141. Mallart, A., Martin, A.R., J. Physiol. (London) 193 (1968), 679–694.
142. Marangos, P.J., Paul, S.M., Parma, A.M., Goodwin, F.K., Syapin, P., Skolnick, P., Life Sci. 24 (1979), 851–858.
143. Marangos, P.J., Boulenger, J.-P., Patel, J., Life Sci. 34 (1984), 899–907.
144. Marley, E., Nistico, G., Br. J. Pharmacol. 46 (1972), 619–636.
145. Michaelis, M.L., Michaelis, E.K., Biochim. Biophys. Acta 648 (1981), 55–62.
146. Michaelis, M.L., Michaelis, E.K., Myers, S.L., Life Sci. 24 (1979), 2083–2092.
147. Minneman, K.P., Quik, M., Emson, P.C., Brain Res. 151 (1978), 507–521.
148. Morgan, P.F., Lloyd, H.G.E., Stone, T.W., Neurosci. Lett. 41 (1983), 183–188.
149. Motley, S.J., Collins, G.G.S., Neuropharmacology 22 (1983), 1081–1086.
150. Moyer, J.H., Tashnek, A.B., Miller, S.I., Snyder, H., Bowman, R.O., Am. J. Med. Sci. 244 (1952), 377–385.
151. Murphy, K.M.M., Snyder, S.H., Life Sci. 28 (1981), 917–920.
152. Murphy, K.M.M., Snyder, S.H., Mol. Pharmacol. 22 (1982), 250–257.
153. Murray, T.F., Eur. J. Pharmacol. 82 (1982), 113–114.
154. Murray, T.F., Cheney, D.L., Neuropharmacology 21 (1982), 575–580.
155. Murray, T.F., Blaker, W.D., Cheney, D.L., Costa, E., J. Pharmacol. Exp. Ther. 222 (1982), 550–554.
156. Nagy, J.I., LaBella, L.A., Buss, M., Daddona, P.E., Science 224 (1984), 166–168.
157. Nakamura, S., Mimori, Y., Iijima, S., Nagata, H., Yamao, S., Kameyama, M., Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M., (eds.) Physiology and Pharmacology of Adenosine Derivatives, 1983, Raven, New York, 21–29.
158. Narumi, S., Kimelberg, H.K., Bourke, R.S., J. Neurochem. 31 (1978), 1479–1490.
159. Nilsson, B., Rehncrona, S., Siesjö, B.K., Purves, M., (eds.) Cerebral Vascular Smooth Muscle and its Control, 1978, Excerpta Medica, Amsterdam, 199–214.
160. Nimit, Y., Skolnick, P., Daly, J.W., J. Neurochem. 36 (1981), 908–912.
161. Okada, Y., Kuroda, Y., Proc. Jpn. Acad. 51 (1975), 491–494.
162. Okada, Y., Kuroda, Y., Eur. J. Pharmacol. 61 (1980), 137–146.
163. Okada, Y., Ozawa, S., Eur. J. Pharmacol. 68 (1980), 483–492.
164. Okada, Y., Saito, M., Brain Res. 160 (1979), 368–371.
165. Oliver, A.P., Hoffer, B.J., Wyatt, R.J., Epilepsia 18 (1979), 543–548.
166. Olpe, H.-R., Jones, R.S.G., Steinmann, M.W., Experientia 39 (1983), 242–249.
167. Patel, J., Marangos, P.J., Stivers, J., Goodwin, F.K., Brain Res. 237 (1982), 203–214.
168. Pedata, F., Antonelli, T., Lambertini, L., Beani, L., Pepeu, G., Neuropharmacology 22 (1983), 609–614.
169. Pepper, C.M., Henderson, G., Science 209 (1980), 394–396.
170. Perkins, M.N., Stone, T.W., Arch. Int. Pharmacodyn. Ther. 246 (1980), 205–214.
171. Perkins, M.N., Stone, T.W., Br. J. Pharmacol. 70 (1980), 425–428.
172. Phillis, J.W., Can. J. Physiol. Pharmacol. 57 (1979), 432–435.
173. Phillis, J.W., J. Pharm. Pharmacol. 34 (1982), 453–454.
174. Phillis, J.W., Clin. Neuropharmacol., 7, 1984, S229.
175. Phillis, J.W., Prog. Neuropsychopharm. Biol. Psychiat. 8 (1984), 495–502.
176. Phillis, J.W., Kostopoulos, G.W., Life Sci. 17 (1975), 1085–1094.
177. Phillis, J.W., Wu, P.H., Prog. Neurobiol. 16 (1981), 187–239.
178. Phillis, J.W., Wu, P.H., Med. Hypoth. 9 (1982), 361–367.
179. Phillis, J.W., Wu, P.H., Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M., (eds.) Physiology and Pharmacology of Adenosine Derivatives, 1983, Raven, New York, 219–236.
180. Phillis, J.W., Kostopoulos, G.W., Limacher, J.J., Can. J. Physiol. Pharmacol. 52 (1974), 1226–1229.
181. Phillis, J.W., Kostopoulos, G.W., Limacher, J.J., Eur. J. Pharmacol. 30 (1975), 125–129.
182. Phillis, J.W., Edstrom, J.P., Ellis, S.W., Kirkpatrick, J.R., Can. J. Physiol. Pharmacol. 57 (1979), 917–920.
183. Phillis, J.W., Edstrom, J.P., Kostopoulos, G.K., Kirkpatrick, J.R., Can. J. Physiol. Pharmacol. 57 (1979), 1289–1312.
184. Phillis, J.W., Siemens, R.K., Wu, P.H., Br. J. Pharmacol. 70 (1980), 341–348.
185. Phillis, J.W., Jiang, Z.G., Chelack, B.J., J. Pharm. Pharmacol. 32 (1980), 871–872.
186. Phillis, J.W., Wu, P.H., Bender, A.S., Gen. Pharmacol. 12 (1981), 67–70.
187. Phillis, J.W., Wu, P.H., Coffin, V.L., Gen. Pharmacol. 14 (1983), 475–479.
188. Polc, P., Bonetti, E.P., Pieri, L., Cumin, R., Angioi, R.M., Möhler, H., Haefely, W.E., Life Sci. 28 (1981), 2265–2275.
189. Pons, F., Bruns, R.F., Daly, J.W., J. Neurochem. 34 (1980), 1319–1323.
190. Potter, P., White, T.D., Neuroscience 5 (1980), 1351–1356.
191. Premont, J., Prez, M., Blanc, G., Tassin, J., Thierry, A., Herve, D., Bockaert, J., Mol. Pharmacol. 16 (1979), 790–804.
192. Proctor, W.R., Dunwiddie, T.V., Neurosci. Lett. 35 (1983), 197–201.
193. Proctor, W.R., Dunwiddie, T.V., Neurosci. Abstr., 9, 1983, 1212.
194. Proctor, W.R., Dunwiddie, T.V., Science 224 (1984), 519–521.
195. Psychoyos, S., Ford, C.J., Phillipps, M.A., Biochem. Pharmacol. 31 (1982), 1441–1442.
196. Pull, I., McIlwain, H., Biochem. J. 136 (1973), 893–901.
197. Raberger, G., Schüutz, W., Kraupp, O., Arch. Int. Pharmacodyn. Ther. 230 (1977), 140–149.
198. Radulovacki, M., Miletich, R.S., Green, R.D., Brain Res. 246 (1982), 178–180.
199. Radulovacki, M., Virus, R.M., Djuricic-Nedelson, M., Green, R.D., Brain Res. 271 (1983), 392–395.
200. Radulovacki, M., Virus, R.M., Djuricic-Nedelson, M., Green, R.D., J. Pharmacol. Exp. Ther. 228 (1984), 268–274.
201. Reddington, M., Schubert, P., Neurosci. Lett. 14 (1979), 37–42.
202. Reddington, M., Lee, K.S., Schubert, P., Neurosci. Lett. 28 (1982), 275–279.
203. Redmond, D.E., J. Clin. Psychiat. 43 (1982), 4–8.
204. Rehncrona, S., Siesjo, B.K., Westerberg, E., Acta Physiol. Scand. 104 (1978), 453–463.
205. Ribeiro, J.A., Sa-Almeida, A.M., Namorado, J.M., Biochem. Pharmacol. 28 (1979), 1297–1300.
206. Ritchie, J.M., Goodman, L.S., Gilman, A., (eds.) The Pharmacological Basis of Therapeutics, 1975, Macmillan, New York, 367–378.
207. Salt, T.E., Hill, R.G., Neurosci. Lett. 35 (1983), 53–57.
208. Sattin, A., Rall, T.W., Mol. Pharmacol. 6 (1970), 13–23.
209. Sawynok, J., Jhamandas, K.H., J. Pharmacol. Exp. Ther. 197 (1976), 379–390.
210. Scholfield, C.N., Br. J. Pharmacol. 63 (1978), 239–244.
211. Schrader, J., Wahl, M., Kuschinsky, W., Kreutzberg, G.W., Pflüger's Arch. 387 (1980), 245–251.
212. Schubert, P., Mitzdorf, U., Brain Res. 172 (1979), 186–190.
213. Schubert, P., Lee, K., West, M., Deadwyler, S., Lynch, G., Nature (London) 260 (1976), 541–542.
214. Schubert, P., Komp, W., Kreutzberg, G.W., Brain Res. 168 (1979), 419–424.
215. Schubert, P., Lee, K., Kreutzberg, G.W., Prog. Brain Res. 55 (1982), 225–238.
216. Schubert, P., Lee, K., Reddington, M., Kreutzberg, G., Berne, R.M., Rall, T.W., Rubio, R., (eds.) Regulatory Function of Adenosine, 1983, Nijhoff, The Hague, 439–454.
217. Schütz, W., Steurer, G., Tuisl, E., Eur. J. Pharmacol. 85 (1982), 177–184.
218. Schütz, W., Kraupp, O., Bacher, S., Raberger, G., Basic Res. Cardiol. 78 (1983), 679–684.
219. Schwabe, U., Trost, T., N. S. Arch. Pharmacol. 313 (1980), 179–187.
220. Segal, M., Eur. J. Pharmacol. 79 (1982), 193–199.
221. Seppala, T., Linnoila, M., Mattila, M., Drugs 17 (1979), 389–408.
222. Siesjö, B.K., Berntman, L., Nilsson, B., Microvasc. Res. 19 (1980), 158–170.
223. Siggins, G.R., Schubert, P., Neurosci. Lett. 23 (1981), 55–60.
224. Silinsky, E.M., J. Physiol. (London) 346 (1984), 243–256.
225. Smellie, F.W., Daly, J.W., Dunwiddie, T.V., Hoffer, B.J., Life Sci. 25 (1979), 1739–1745.
226. Smellie, F.W., Davis, C.W., Daly, J.W., Wells, J.N., Life Sci. 24 (1979), 2475–2482.
227. Snyder, S.H., Trends Neurosci. 4 (1981), 242–244.
228. Snyder, S.H., Bruns, R.F., Daly, J.W., Innis, R.B., Fed. Proc., Fed. Am. Soc. Exp. Biol. 40 (1981), 142–146.
229. Snyder, S.H., Katims, J.J., Annau, Z., Bruns, R.F., Daly, J.W., Proc. Natl. Acad. Sci. U.S.A. 78 (1981), 3260–3264.
230. Spencer, D.G., Lal, H., Life Sci. 32 (1983), 2329–2333.
231. Stone, T.W., Brain Res. 182 (1980), 198–200.
232. Stone, T.W., Neuroscience 6 (1981), 523–555.
233. Stone, T.W., Br. J. Pharmacol. 74 (1981), 171–176.
234. Stone, T.W., Brain Res. 248 (1982), 367–370.
235. Stone, T.W., Daly, J.W., Kuroda, Y., Phillis, J.W., Shimizu, H., Ui, M., (eds.) Physiology and Pharmacology of Adenosine Derivatives, 1983, Raven, New York, 237–244.
236. Stone, T.W., Berne, R.M., Rall, T.W., Rubio, R., (eds.) Regulatory Function of Adenosine, 1983, Nijhoff, The Hague, 467–477.
237. Stone, T.W., Taylor, D.A., Exp. Neurol. 70 (1980), 556–566.
238. Stone, T.W., Hollins, C., Lloyd, H., Brain Res. 207 (1981), 421–431.
239. Su, C., Annu. Rev. Pharmacol. Toxicol. 23 (1983), 397–411.
240. Tabakoff, B., Hoffman, P.L., Ritzman, R.F., Seixas, F.A., (eds.) Currents in Alcoholism, 1978, Grune & Stratton, New York, 97–118.
241. Thesleff, S., Neuroscience 5 (1980), 1413–1419.
242. Thithapandha, A., Maling, H.M., Gillete, J.R., Proc. Soc. Exp. Biol. Med. 139 (1972), 582–586.
243. Van Calker, D., Müller, M., Hamprecht, B., J. Neurochem. 33 (1979), 999–1005.
244. Vapaatalo, H., Onken, D., Neuvonen, P., Westerman, E., Arzneimittel forsch. 25 (1975), 407–410.
245. Verhaege, R.H., Vanhoutte, P.M., Shepard, J.T., Circ. Res. 40 (1977), 208–215.
246. Vizi, E.S., Knoll, J., Neuroscience 1 (1976), 391–398.
247. Vizi, E.S., Somogyi, G.T., Magyar, K., Auton. Pharmacol. 1 (1981), 413–419.
248. Vlahov, V., Zafirov, D., Acta Physiol Pharmacol. Bulg. 7 (1981), 61–68.
249. Wahl, M., Kuschinsky, W., Pfluegers Arch. 362 (1976), 55–59.
250. Weber, A.M., Herz, R., J. Gen. Physiol. 52 (1968), 750–759.
251. Wechsler, R.L., Kleiss, L.M., Kety, S.S., J. Clin. Invest. 29 (1950), 28–30.
252. Weiner, M., Olson, J.W., Psychopharmacology 54 (1977), 61–65.
253. Whittaker, V.P., Dowdall, M.J., Boyne, A.F., Biochem. Soc. Symp. 36 (1972), 49–68.
254. Williams, M., Prog. Neuropsychopharmacol. Biol. Psychiat. 7 (1983), 443–450.
255. Williams, M., Handb. Neurochem. 6 (1983), 1–18.
256. Williams, M., Trends Neurosci. 7 (1984), 164–168.
257. Williams, M., Risley, E.A., Proc. Natl. Acad. Sci. U.S.A. 77 (1980), 6892–6896.
258. Winkler, H., Neuroscience 2 (1977), 657–683.
259. Winn, H.R., Rubio, R., Berne, R.M., Circ. Res. 45 (1979), 486–492.
260. Winn, H.R., Welsh, J.E., Rubio, R., Berne, R.M., Am. J. Physiol. 239 (1980), H636–H641.
261. Winn, H.R., Welsh, J.E., Rubio, R., Berne, R.M., Circ. Res. 47 (1980), 568–577.
262. Winn, H.R., Welsh, J.E., Rubio, R., Berne, R.M., Circ. Res. 47 (1980), 481–491.
263. Winn, H.R., Rubio, R., Berne, R.M., Am. J. Physiol. 241 (1981), H235–H242.
264. Wojcik, W.J., Neff, N.H., J. Neurochem. 39 (1982), 280–282.
265. Wojcik, W.J., Neff, N.H., Life Sci. 33 (1983), 755–763.
266. Wojcik, W.J., Neff, N.H., Neurosci. Lett. 41 (1983), 55–60.
267. Wojcik, W.J., Neff, N.H., J. Neurochem. 41 (1983), 759–763.
268. Wu, P.H., Coffin, V.L., Brain Res. 294 (1984), 186–189.
269. Wu, P.H., Phillis, J.W., Neurochem. Int. 6 (1984), 613–632.
270. Wu, P.H., Phillis, J.W., Thierry, D.L., J. Neurochem. 39 (1982), 700–708.
271. Yarbrough, G.G., McGuffin-Clineschmidt, J.C., Eur. J. Pharmacol. 76 (1981), 137–144.
272. Yeung, S.-M.H., Green, R.D., N. S. Arch. Pharmacol. 325 (1984), 218–225.
273. York, M.J., Davies, L.P., Can. J. Physiol. Pharmacol. 60 (1982), 302–307.
274. Zetterström, T., Vernet, L., Ungerstedt, U., Tossman, U., Jonzon, B., Fredholm, B.B., Neurosci. Lett. 29 (1982), 111–115.